Diametric Capital, LP Bristol Myers Squibb CO Transaction History

Diametric Capital, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $342,313 - $380,086	5,373 New	5,373 $343,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $4,885 - $2.89 Million	37,584 New	37,584 $2.67 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $975,276 - $1.08 Million	-16,982 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $930,953 - $1.09 Million	16,982 New	16,982 $999,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $1.9 Million - $2.76 Million	-40,901 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $697,010 - $909,187	-14,164 Reduced 25.72%	40,901 $2.63 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $2.36 Million - $2.79 Million	55,065 New	55,065 $2.77 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $1.21 Million - $1.44 Million	-26,815 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $416,166 - $539,668	8,535 Added 46.69%	26,815 $1.39 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $264,856 - $298,737	-4,799 Reduced 20.79%	18,280 $1.13 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $93,783 - $116,890	-1,856 Reduced 7.44%	23,079 $1.28 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $483,973 - $557,151	-8,077 Reduced 24.47%	24,935 $1.58 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $1.98 Million - $2.16 Million	33,012	33,012 $2.02 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.